Literature DB >> 2220730

Percutaneous transhepatic cholecystostomy for acute complicated cholecystitis in elderly patients.

W Van Steenbergen1, E Ponette, G Marchal, W Pelemans, R Aerts, J Fevery, J De Groote.   

Abstract

We report our experience with percutaneous transhepatic cholecystostomy in 10 elderly patients with acute cholecystitis, complicated by empyema formation. Most of these patients has severe underlying disease, rendering them at high risk for surgical intervention. In all patients, the percutaneous procedure was followed by a rapid regression of clinical symptoms and of radiologic abnormalities. Six were considered inoperable. Three of these remain free of biliary symptoms, respectively 22, 10, and 7 months after percutaneous cholecystostomy. Three others died of nonbiliary disease 1-4 months after cholecystostomy. Three patients underwent successful elective cholecystostomy 1-5 wk after percutaneous cholecystostomy. In one patient, cholecystectomy had to be performed because of recurrence of hydrops, 1 wk after catheter removal. In our opinion, percutaneous transhepatic cholecystostomy is a safe and effective procedure in the treatment of elderly patients with acute complicated cholecystitis. It can be followed by elective cholecystectomy in good surgical candidates, or by an expectant conservative management in high surgical risk patients.

Entities:  

Mesh:

Year:  1990        PMID: 2220730

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

1.  Surgical outcomes of laparoscopic cholecystectomy for severe acute cholecystitis.

Authors:  Ji Hun Kim; Jeong Woon Kim; In Ho Jeong; Tae Yong Choi; Byung Moo Yoo; Jin Hong Kim; Myung Wook Kim; Wook Hwan Kim
Journal:  J Gastrointest Surg       Date:  2008-03-08       Impact factor: 3.452

2.  Systematic review of cholecystostomy as a treatment option in acute cholecystitis.

Authors:  Anders Winbladh; Per Gullstrand; Joar Svanvik; Per Sandström
Journal:  HPB (Oxford)       Date:  2009-05       Impact factor: 3.647

3.  Percutaneous cholecystostomy for high-risk patients with acute cholecystitis.

Authors:  K Welschbillig-Meunier; P Pessaux; J Lebigot; E Lermite; Ch Aube; O Brehant; A Hamy; J P Arnaud
Journal:  Surg Endosc       Date:  2005-07-14       Impact factor: 4.584

Review 4.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

5.  Short- and long-term outcomes following percutaneous cholecystostomy for acute cholecystitis in high-risk patients.

Authors:  Andrew McKay; Moaz Abulfaraj; Jeremy Lipschitz
Journal:  Surg Endosc       Date:  2011-11-17       Impact factor: 4.584

6.  Percutaneous cholecystostomy as the sole treatment in critically ill and elderly patients.

Authors:  G Carrafiello; A D'Ambrosio; M Mangini; M Petullà; G L Dionigi; A M Ierardi; F Piacentino; F Fontana; C Fugazzola
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

7.  Better treatment strategies for patients with acute cholecystitis and American Society of Anesthesiologists classification 3 or greater.

Authors:  Sung Su Yun; Dae Wook Hwang; Se Won Kim; Sang Hwan Park; Sang Jin Park; Dong Shick Lee; Hong Jin Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

8.  Acute gallstone cholecystitis in the elderly: treatment with emergency ultrasonographic percutaneous cholecystostomy and interval laparoscopic cholecystectomy.

Authors:  A Macrì; G Scuderi; E Saladino; G Trimarchi; M Terranova; A Versaci; C Famulari
Journal:  Surg Endosc       Date:  2005-12-07       Impact factor: 3.453

9.  Endoscopic gallbladder drainage for acute cholecystitis with high-risk surgical patients between transduodenal and transpapillary stenting.

Authors:  Kyouhei Nishiguchi; Takeshi Ogura; Atsushi Okuda; Saori Ueno; Nobu Nishioka; Masanori Yamada; Jun Matsuno; Kazuya Ueshima; Yoshitaro Yamamoto; Kazuhide Higuchi
Journal:  Endosc Ultrasound       Date:  2021 Nov-Dec       Impact factor: 5.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.